Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

BoStOn Scientific Rhythm Management REGISTER (SOCRATES) (SOCRATES)

30 oktober 2026 uppdaterad av: Boston Scientific Corporation

BoStOn Scientific Rhythm Management REGISTER

SOCRATES is part of Boston Scientific's (BSC) Post-market surveillance system. The implementation of such systems is mandatory per local regulations such as the Regulation '(EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices' or short Medical Device Regulation (MDR). The SOCRATES design is therefore based on the BSC's commitment as well as external regulatory requirements to proactively and systematically gather, record and analyze relevant data on the quality, performance and safety of devices throughout their entire lifetime.

Studieöversikt

Status

Rekrytering

Betingelser

Detaljerad beskrivning

SOCRATES is a non-randomized, multisite, single-arm, open-label, global post-market observational data collection per standard of care. While generally of prospective design, a limited retrospective element is allowed for the inclusion of patients for a short period of 10 days after their index procedure.

SOCRATES intends to enroll a number of subjects that will support the analysis of all the individual Post Market Clinical Follow-Up (PMCF) Plans. An average of approximately 100 subjects per year and site on a continuous basis is expected but may vary depending on the needs of individual PMCF Plans. As long as SOCRATES is active, there is no upper limit to the total number of subjects that may be enrolled, and enrollment will be driven by the need to support sample sizes of individual PMCF plans for given products/product groupings supported by SOCRATES.

SOCRATES is designed to be a continuous effort after the data collection commences without a predefined closure timepoint. Data collection and enrollment may be stopped, restarted or finalized per Sponsor discretion.

The expected duration of SOCRATES participation for a subject is dependent on

  • the specific lifetime of the device (e.g. the battery usage for pulse generators or continued active use of leads for CRM devices) or
  • the necessary timeframe to adequately assess safety and performance of the device based on the residual risk assessed for each device in the associated PMCF plan. Timeframes might e.g. spread from 7 days to one year post procedure for EP. The maximum duration per enrolled subject will consequently vary.

For BSC implantable devices subjects are intended to be followed for the entire time of being implanted with a BSC device to allow data collection over the lifetime of the device(s) as required by applicable regulations. A maximum duration per enrolled subject is not defined, unless locally required. In case a local maximum duration is enforced subjects may be consented again and re-enrolled for continued participation if they are still in scope for SOCRATES. Sites shall ensure continuous data collection without any gaps in case a re-enrollment becomes applicable. Data sets for re-enrolled subjects will be handled as if the subject was continuously enrolled. This process will ensure to meet the requirement of MDR for device manufacturers to collect data over the lifetime of the devices.

Studietyp

Observationell

Inskrivning (Beräknad)

12500

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

Studieorter

      • Jette, Belgien, 1090
        • Rekrytering
        • Universitair Ziekenhuis Brussel
        • Kontakt:
          • Carlo de Asmundis, Prof.
      • Yvoir, Belgien, 5530
        • Rekrytering
        • CHU UCL Namur - Site Godinne
        • Kontakt:
          • Dominique Blommaert, Prof.
      • Brest, Frankrike, 29200
        • Rekrytering
        • CHRU de Brest, Hôpital de la Cavale Blanche
        • Kontakt:
          • Jacques Mansourati, Prof.
      • Clermont-Ferrand, Frankrike, 63000
        • Rekrytering
        • CHRU de Clermont-Ferrand
        • Kontakt:
          • Romain Eschalier, MD
      • Lomme, Frankrike, 59462
        • Rekrytering
        • Hopital Saint Philibert
        • Kontakt:
          • Aymeric Menet, MD
      • Pau, Frankrike
        • Rekrytering
        • CHG de Pau
        • Kontakt:
          • Hugues Bader, MD
      • Saint-Etienne, Frankrike, 42055
        • Rekrytering
        • CHU de Saint-Etienne
        • Kontakt:
          • Antoine Da Costa, Prof.
      • Athens, Grekland, 17674
        • Rekrytering
        • Onassis Cardiac Surgery Center
        • Kontakt:
          • Michael Ephremidis, MD
      • Athens, Grekland, 11527
        • Avslutad
        • General Hospital of Athens "G. Gennimatas"
      • Dublin, Irland, D07 WKW8
        • Rekrytering
        • Mater Private Hospital
        • Kontakt:
          • Gabor Szeplaki, Prof.
      • Ramat Gan, Israel, 52621
        • Rekrytering
        • Sheba Medical Center
        • Kontakt:
          • Roy Beinart, MD
      • Tel Aviv, Israel, 6423906
        • Rekrytering
        • Tel Aviv Sourasky Medical Center
        • Kontakt:
          • Raphael Rosso, Professor
      • Tel Aviv, Israel, 62431
        • Rekrytering
        • Tel Aviv Sourask Medical Center
        • Kontakt:
          • Raphael Rosso, Professor
      • Modena, Italien, 41124
        • Rekrytering
        • Policlinico di Modena
        • Kontakt:
          • Giuseppe Boriani, Prof.
      • Roma, Italien, 00168
        • Rekrytering
        • Policlinico Universitario Agostino Gemelli
        • Kontakt:
          • Gemma Pelargonio, MD
      • Roma, Italien, 00169
        • Rekrytering
        • Policlinico Casilino
        • Kontakt:
          • Leonardo Calò, MD
      • Roma, Italien, 00186
        • Rekrytering
        • Ospedale S.G. Calibita Fatebenefratelli - Isola Tiberina
        • Kontakt:
          • Stefano Bianchi, MD
    • Quebec
      • Québec, Quebec, Kanada, G1V 4G5
        • Rekrytering
        • Institut Universitaire de Cardiologie et de Pneumologie de Quebec
        • Kontakt:
          • Jean-Francois Sarrazin, MD
      • Madrid, Spanien, 28040
        • Rekrytering
        • Hospital Clinico San Carlos
        • Kontakt:
          • Nicasio Pérez Castellano, MD
      • San Cristóbal de La Laguna, Spanien, 38320
        • Rekrytering
        • Hospital Universitario de Canarias
        • Kontakt:
          • Francisco Bosa Ojeda, MD
      • Santa Cruz de Tenerife, Spanien, 38010
        • Rekrytering
        • Hospital Nuestra Señora de La Candelaria
        • Kontakt:
          • Luis A. Acosta, MD
      • Zaragoza, Spanien, 50009
        • Rekrytering
        • Hospital Universitario Miguel Servet
        • Kontakt:
          • Antonio Asso Abadía, MD
      • London, Storbritannien, EC1A 7BE
        • Rekrytering
        • St. Bartholomew's Hospital
        • Kontakt:
          • Ross Hunter, Prof.
      • Manchester, Storbritannien, M13 9WL
        • Rekrytering
        • Manchester Heart Center
        • Kontakt:
          • Charles Pearman, MD
      • Berlin, Tyskland, 12687
        • Rekrytering
        • Unfallkrankenhaus Berlin Marzahn
        • Kontakt:
          • Corinna Lenz, MD
      • Bochum, Tyskland, 44791
        • Avslutad
        • Augusta Kranken Anstalt GmbH

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Barn
  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Testmetod

Icke-sannolikhetsprov

Studera befolkning

The subjects will be recruited from the general patient population of the participating centers who are

  • receiving diagnosis or treatment using a BSC product in scope of SOCRATES and
  • fulfilling all inclusion criteria and none of the exclusion criteria.

Beskrivning

Inclusion Criteria:

  1. Subject is willing and capable of providing informed consent and/or to give approval to collect/store/process personal health information by the sponsor or such consent/approval is provided by a legally designated representative, if required by local law or regulation.
  2. Subject is (one criterion must be fulfilled) a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii. the BSC CRM product implant.

Exclusion Criteria:

  1. Subject is foreseen not to be followed at the enrolling center for at least 1 year after an implant procedure (CRM) or at least 1 month (EP).
  2. Subject is receiving diagnosis or therapy by means of any product, that is not approved for commercial use at the time of implant/procedure.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiv: OTHER

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
BSC Product Use

Subject fulfilling one of the following conditions:

a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii.the BSC CRM product implant.

In the scope of the CRM procedure and subsequent follow-up, the registry will provide information on the use of the Boston Scientific CRM products/components and combination of those products/components with competitor product(s) per hospital's standard of care.

In the scope of the EP procedure and subsequent follow-up, the registry will provide information on the use of the Boston Scientific Electrophysiology products/components and capital equipment products and combination of those products/components with competitor product(s) per hospital's standard of care.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
System-related complication free rate
Tidsram: From Cardiac Rhythm Management (CRM) device implant on day 0 through follow-up up to 10 years; from electrophysiological (EP) procedure on day 0 through follow-up from 30 days up to 1 year

Freedom from complications related to system

From Cardiac Rhythm Management (CRM) device implant on day 0 through follow-up up to 10 years; from electrophysiological (EP) procedure on day 0 through follow-up from 30 days up to 1 year
Rate of product related performance deficiencies per product or product group
Tidsram: CRM implant on day 0; EP procedure on day 0

Performance of product/product group at implant/procedure

CRM implant on day 0; EP procedure on day 0
Rate of product related performance deficiencies per product or product group
Tidsram: CRM implant on day 0 through the implanted duration up to 10 years

Performance of product/product group through the implanted duration

CRM implant on day 0 through the implanted duration up to 10 years

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Studierektor: Eszter Pais, MD, Boston Scientific Corporation

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

31 mars 2021

Primärt slutförande (Beräknad)

31 december 2030

Avslutad studie (Beräknad)

31 december 2030

Studieregistreringsdatum

Först inskickad

18 mars 2021

Först inskickad som uppfyllde QC-kriterierna

26 mars 2021

Första postat (Faktisk)

1 april 2021

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

2 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

30 oktober 2026

Senast verifierad

1 oktober 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera